Adhera Therapeutics, Inc.

ATRXOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$722

P/E Ratio—

52W High$0.01

52W Low$0.0001

Avg Volume354

Open$0.00

Beta3.73

Net Income Financials Revenue

Adhera Therapeutics, Inc. (ATRX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ATRX · net income · updated Jun 8, 2026

Core profitability metrics

ATRX · net income · margin · TTM · CAGR

Net income was −$2.1M for FY2022 (fiscal year ending 2022-12-31), up 66.7% year-over-year. Net profit margin was —. Based on available data, Adhera Therapeutics, Inc. has been profitable since at least 2015.

FY2022 Net Income−$2.1M▲ +66.7% YoY

Trailing 12M (TTM)−$4.5Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+66.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2015

▸ FMP /income-statement · Annual · ATRX net income history · ATRX profit margin

Annual net income data

ATRX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$2.1M▲ +66.7%—$0

FY2021Loss−$6.4M▼ 68.6%—$0

FY2020Loss−$3.8M▲ +68.6%—$0

FY2019Loss−$12.0M▲ +28.5%-4753.2%$252,000

FY2018Loss−$16.8M▼ 169.4%-21992.2%$76,186

Net income vs peers (Healthcare)

ATRX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Adhera Therapeutics, Inc.YOU

ATRX

−$2.1M+66.7%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Adhera Therapeutics, Inc. (ATRX) reported net income of −$2.1M for FY2022 (fiscal year ending 2022-12-31), up 66.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Adhera Therapeutics, Inc. has been profitable since at least 2015. Net income reached a peak of $3.3M in FY2015. Data available for 15 fiscal years.

Adhera Therapeutics, Inc.'s net profit margin was — for FY2022, based on the latest annual results.

Investors sometimes search for "Adhera Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from ATRX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ATRX net income · 4 questions

Adhera Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $2.1M for FY2022.

is ATRX profitabledoes ATRX make a profitATRX profitabilityATRX profitable company

▸ Source: FMP /income-statement · GAAP · Adhera Therapeutics, Inc. · Adhera Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026